A cell model that replicates the structure and function of the human intestine has been developed, creating an evaluation platform capable of more accurately predicting adverse effects of new drugs.
In this White Paper, MatTek, now part of Sartorius, details a highly differentiated 3D small-intestine tissue model that uses primary human stem cells to provide a more accurate alternative to animal ...
A stem cell-derived intestine model reveals glycyrrhizin as a potential treatment for inflammatory bowel disease.
SAN DIEGO - VivoSim Labs, Inc. (NASDAQ:VIVS) announced today at the Society of Toxicology meeting that its NAMkind liver and intestine models have been validated for predicting toxicity profiles of ...
SAN DIEGO, May 13, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (VIVS) (the “Company” or “VivoSim”) announced today that its NAMkind™ platform for intestinal efficacy prediction was recognized with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results